Critical review on the presence of phthalates in food and evidence of their biological impact

A Giuliani, M Zuccarini, A Cichelli, H Khan… - International journal of …, 2020 - mdpi.com
Phthalates are a huge class of chemicals with a wide spectrum of industrial uses, from the
manufacture of plastics to food contact applications, children's toys, and medical devices …

Histone deacetylase 6 in cancer

T Li, C Zhang, S Hassan, X Liu, F Song, K Chen… - Journal of hematology & …, 2018 - Springer
Histone acetylation and deacetylation are important epigenetic mechanisms that regulate
gene expression and transcription. Histone deacetylase 6 (HDAC6) is a unique member of …

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

A Lin, CJ Giuliano, A Palladino, KM John… - Science translational …, 2019 - science.org
Ninety-seven percent of drug-indication pairs that are tested in clinical trials in oncology
never advance to receive US Food and Drug Administration approval. While lack of efficacy …

[HTML][HTML] Histone deacetylases and cancer

B Barneda-Zahonero, M Parra - Molecular oncology, 2012 - Elsevier
Reversible acetylation of histone and non-histone proteins is one of the most abundant post-
translational modifications in eukaryotic cells. Protein acetylation and deacetylation are …

Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes

Y Li, D Shin, SH Kwon - The FEBS journal, 2013 - Wiley Online Library
Histone deacetylase (HDAC) 6 is the best‐characterized class II b deacetylase that
regulates many important biological processes via the formation of complexes with its …

The role of HDAC6 in cancer

GI Aldana-Masangkay… - BioMed Research …, 2011 - Wiley Online Library
Histone deacetylase 6 (HDAC6), a member of the HDAC family whose major substrate is α‐
tubulin, has become a target for drug development to treat cancer due to its major …

[HTML][HTML] HDAC inhibitor-based therapies: can we interpret the code?

M New, H Olzscha, NB La Thangue - Molecular oncology, 2012 - Elsevier
Abnormal epigenetic control is a common early event in tumour progression, and aberrant
acetylation in particular has been implicated in tumourigenesis. One of the most promising …

HDAC6: A unique HDAC family member as a cancer target

S Kaur, P Rajoria, M Chopra - Cellular Oncology, 2022 - Springer
Background HDAC6, a structurally and functionally distinct member of the HDAC family, is
an integral part of multiple cellular functions such as cell proliferation, apoptosis …

Histone deacetylase 6 in health and disease

C Seidel, M Schnekenburger, M Dicato… - Epigenomics, 2015 - Taylor & Francis
Histone deacetylase (HDAC) 6 is a member of the class IIb HDAC family. This enzyme is
zinc-dependent and mainly localized in the cytoplasm. HDAC6 is a unique isoenzyme with …

Nonhistone protein acetylation as cancer therapy targets

BN Singh, G Zhang, YL Hwa, J Li… - Expert review of …, 2010 - Taylor & Francis
Acetylation and deacetylation are counteracting, post-translational modifications that affect a
large number of histone and nonhistone proteins. The significance of histone acetylation in …